Nuzenio

After Divesiran Phase

After Divesiran Phase news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 15 publisher sources 100/100 entity strength

Latest news

Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial - MarketBeatMarketBeat · Tue, 11 Aug 2026 05:28:59 GMTDivesiran Eliminates Need for Phlebotomy in 88% of Patients With Polycythemia Vera - Cure TodayCure Today · Mon, 10 Aug 2026 20:53:09 GMTHPE Shares Climb Following Morgan Stanley Upgrade, With $71 Price Target Indicating 30% Upside - TechStock²TechStock² · Mon, 10 Aug 2026 20:44:58 GMTSilence Therapeutics Jumps Over 25% After Divesiran Phase 2 Trial Supports 12-Week Dosing - TechStock²TechStock² · Mon, 10 Aug 2026 20:28:54 GMTSandisk Stock Rebounds as Analysts Reframe the Earnings Selloff - TechStock²TechStock² · Mon, 10 Aug 2026 20:11:59 GMTSilence posts mid-stage polycythemia vera win, preps for Phase III - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 18:02:18 GMTSilence Therapeutics Says Blood Cancer Trial Delivers 'Best-Case Outcome' - BenzingaBenzinga · Mon, 10 Aug 2026 14:15:58 GMTSilence Therapeutics Announces Positive Phase 2 SANRECO Trial Outcomes for Divesiran in Polycythemia Vera - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 14:00:27 GMT

Timeline

Tue, 11 Aug 2026 05:28:59 GMTSilence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial - MarketBeat
Mon, 10 Aug 2026 20:53:09 GMTDivesiran Eliminates Need for Phlebotomy in 88% of Patients With Polycythemia Vera - Cure Today
Mon, 10 Aug 2026 20:44:58 GMTHPE Shares Climb Following Morgan Stanley Upgrade, With $71 Price Target Indicating 30% Upside - TechStock²
Mon, 10 Aug 2026 20:28:54 GMTSilence Therapeutics Jumps Over 25% After Divesiran Phase 2 Trial Supports 12-Week Dosing - TechStock²
Mon, 10 Aug 2026 20:11:59 GMTSandisk Stock Rebounds as Analysts Reframe the Earnings Selloff - TechStock²
Mon, 10 Aug 2026 18:02:18 GMTSilence posts mid-stage polycythemia vera win, preps for Phase III - FirstWord Pharma

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for After Divesiran Phase.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

15 distinct publisher/source names are currently connected to this entity page.